Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 8;32(9):577.
doi: 10.1007/s00520-024-08735-5.

The validity of over-the-counter skin, hair, and nail recommendations for adult patients with cancer: A systematic review

Bahar Javdan  1 , Lindsay M Pattison  2 , Sneha A Rangu  2 , Emely Tejeda  2 , Beth N McLellan  3
Affiliations

The validity of over-the-counter skin, hair, and nail recommendations for adult patients with cancer: A systematic review

Bahar Javdan et al. Support Care Cancer. .

Abstract

Importance: Patients undergoing cancer treatment experience a multitude of skin, hair, and nail adverse events, prompting them to use non-evidence-based and often restrictive over-the-counter (OTC) recommendations to alleviate their symptoms. Comprehensively assessing evidence-based OTC modalities is crucial to enable cancer patients to comfortably resume their lives post-treatment and integrate clinically sound practices into their self-care routines.

Objective: Perform a systematic review and assessment of evidence-based OTC skin, hair, and nail care recommendations for adult patients undergoing cancer treatment.

Evidence review: PubMed, Cochrane, Embase, and Medline databases were searched in March 2023 to identify English articles addressing OTC skin, hair, and nail care recommendations for adult patients before, during, and after cancer chemotherapy or radiation therapy (RT). Quality was assessed with Oxford Centre for Evidence Based Medicine criteria.

Findings: 2192 unique articles were screened, of which 77 met inclusion criteria consisting of 54 randomized controlled trials (RCT), 8 non-randomized controlled cohorts, 1 non-randomized controlled clinical trial, 3 controlled prospective cohorts, 4 prospective cohorts, 2 controlled clinical trials, 1 prospective comparative study, 2 case reports, and 2 case series discussing 9322 patients. An additional article outside of our database search was included for a total of 78 articles. OTC skin care treatments with the best quality of evidence included moisturizing creams. Our review revealed a paucity of evidence-based hair and nail care practices.

Conclusions and relevance: This systematic review serves to highlight the efficacy of diverse OTC skin, hair, and nail care recommendations for adult cancer patients while encouraging further clinical trials to establish evidence-based management guidelines.

Keywords: Chemotherapy; Hair; Nails; Over the counter recommendations; Skincare.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1
Flowchart illustrating article selection process
See this image and copyright information in PMC

References

    1. Alley E, Green R, Schuchter L (2002) Cutaneous toxicities of cancer therapy. Curr Opin Oncol 14(2):212–216. 10.1097/00001622-200203000-00012 - PubMed
    1. Branzan AL, Landthaler M, Szeimies R-M (2005) [Skin changes with chemotherapy]. Hautarzt Z Dermatol Venerol Verwandte Geb 56(6):591–602. 10.1007/s00105-005-0971-0. (quiz 603) - PubMed
    1. Zarrabi K, Gemmill JAL, Safaee M, Baer L (2019) Managing dermatologic changes of targeted cancer therapy. J Fam Pract 68(6):334–340 - PubMed
    1. Bouhanna P (2021) Alopecia after certain cancer treatments. Dermatologie Pratique. https://www.eyecare.fr/img/cms/outils/Hors%20se%CC%81rie-septembre%20202...
    1. Sherman DW, Walsh SM (2022) Promoting comfort: a clinician guide and evidence-based skin care plan in the prevention and management of radiation dermatitis for patients with breast cancer. Healthcare 10(8):1496. 10.3390/healthcare10081496 - PMC - PubMed

Publication types

Substances

LinkOut - more resources